首页 > 最新文献

Osong Public Health and Research Perspectives最新文献

英文 中文
Points to consider when developing drugs for dry eye syndrome. 在开发治疗干眼症的药物时需要考虑的几点。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-04-01 DOI: 10.24171/j.phrp.2023.0031
Suyoung Bae, Hosun Seung, Ho Jung Oh

Changes in both the social environment (e.g., the increased use of electronic media) and the atmospheric environment (e.g., air pollution and dust) have contributed to an increasing incidence of eye disease and an increased need for eye care. Notably, the signs and symptoms of dry eye syndrome can impact the daily quality of life for various age groups, including the elderly, and usually requires active treatment. The symptoms of dry eye syndrome include tear film instability, hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities. As treatments for dry eye are being developed, a standardized guideline is needed to increase the efficiency of drug development and improve the quality of clinical trial data. In this paper, we present general considerations for the pharmaceutical industry and clinical trial investigators designing clinical trials focused on the development of drugs to treat dry eye syndrome.

社会环境(例如,电子媒体的使用增加)和大气环境(例如,空气污染和灰尘)的变化导致眼病发病率增加,对眼睛护理的需求增加。值得注意的是,干眼综合征的体征和症状会影响包括老年人在内的各个年龄组的日常生活质量,通常需要积极治疗。干眼综合征的症状包括泪膜不稳定、高渗、眼表炎症和损伤以及神经感觉异常。随着干眼症治疗方法的发展,需要一个标准化的指南来提高药物开发效率和提高临床试验数据的质量。在本文中,我们提出了制药行业和临床试验研究者设计临床试验的一般考虑,重点是开发治疗干眼综合征的药物。
{"title":"Points to consider when developing drugs for dry eye syndrome.","authors":"Suyoung Bae,&nbsp;Hosun Seung,&nbsp;Ho Jung Oh","doi":"10.24171/j.phrp.2023.0031","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0031","url":null,"abstract":"<p><p>Changes in both the social environment (e.g., the increased use of electronic media) and the atmospheric environment (e.g., air pollution and dust) have contributed to an increasing incidence of eye disease and an increased need for eye care. Notably, the signs and symptoms of dry eye syndrome can impact the daily quality of life for various age groups, including the elderly, and usually requires active treatment. The symptoms of dry eye syndrome include tear film instability, hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities. As treatments for dry eye are being developed, a standardized guideline is needed to increase the efficiency of drug development and improve the quality of clinical trial data. In this paper, we present general considerations for the pharmaceutical industry and clinical trial investigators designing clinical trials focused on the development of drugs to treat dry eye syndrome.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"70-75"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/53/j-phrp-2023-0031.PMC10211449.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estimated impact of the national hepatitis B immunization program on acute viral hepatitis B among adolescents in Republic of Korea. 韩国国家乙型肝炎免疫规划对青少年急性病毒性乙型肝炎的估计影响。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-04-01 DOI: 10.24171/j.phrp.2022.0321
Chungman Chae, Sangwoo Tak

Objectives: We aimed to estimate the impact of the national hepatitis B immunization program on the incidence of acute hepatitis B infection among adolescents in South Korea.

Methods: We estimated the counterfactual incidence rate of reported acute hepatitis B among adolescents from 2016 to 2020 compared to the assumption that the national hepatitis B immunization program for children had not been implemented since 1995. The impact of the national hepatitis B immunization program for adolescents was measured by estimating the absolute risk reduction and averted acute hepatitis B infections among adolescents from 2016 to 2020 attributed to the national immunization program.

Results: The relative risk reduction of acute hepatitis B among adolescents was estimated to be 83.5% after implementing the national hepatitis B immunization program. The incidence rate of reported acute hepatitis B infections among adolescents decreased from 0.39 to 0.06 per 100,000 person-years, and 43 acute hepatitis B infections, including 17 symptomatic cases, were averted annually from 2016 to 2020 by the national hepatitis B immunization program.

Conclusion: The national hepatitis B immunization program for children was effective in preventing acute hepatitis B infection among adolescents in South Korea.

目的:我们旨在评估国家乙肝免疫计划对韩国青少年急性乙肝感染发生率的影响。方法:与1995年以来未实施国家儿童乙型肝炎免疫规划的假设相比,我们估计了2016年至2020年报告的青少年急性乙型肝炎的反事实发病率。通过估计2016年至2020年国家免疫规划导致的青少年急性乙型肝炎感染的绝对风险降低和避免,来衡量国家乙型肝炎免疫规划对青少年的影响。结果:实施国家乙肝免疫规划后,青少年急性乙肝相对危险度降低83.5%。青少年急性乙型肝炎报告感染率从0.39 / 10万人/年下降到0.06 / 10万人/年,2016 - 2020年国家乙肝免疫规划每年避免43例急性乙型肝炎感染,其中有症状的17例。结论:韩国国家儿童乙型肝炎免疫规划在预防青少年急性乙型肝炎感染方面是有效的。
{"title":"Estimated impact of the national hepatitis B immunization program on acute viral hepatitis B among adolescents in Republic of Korea.","authors":"Chungman Chae,&nbsp;Sangwoo Tak","doi":"10.24171/j.phrp.2022.0321","DOIUrl":"https://doi.org/10.24171/j.phrp.2022.0321","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to estimate the impact of the national hepatitis B immunization program on the incidence of acute hepatitis B infection among adolescents in South Korea.</p><p><strong>Methods: </strong>We estimated the counterfactual incidence rate of reported acute hepatitis B among adolescents from 2016 to 2020 compared to the assumption that the national hepatitis B immunization program for children had not been implemented since 1995. The impact of the national hepatitis B immunization program for adolescents was measured by estimating the absolute risk reduction and averted acute hepatitis B infections among adolescents from 2016 to 2020 attributed to the national immunization program.</p><p><strong>Results: </strong>The relative risk reduction of acute hepatitis B among adolescents was estimated to be 83.5% after implementing the national hepatitis B immunization program. The incidence rate of reported acute hepatitis B infections among adolescents decreased from 0.39 to 0.06 per 100,000 person-years, and 43 acute hepatitis B infections, including 17 symptomatic cases, were averted annually from 2016 to 2020 by the national hepatitis B immunization program.</p><p><strong>Conclusion: </strong>The national hepatitis B immunization program for children was effective in preventing acute hepatitis B infection among adolescents in South Korea.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"138-145"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fb/bf/j-phrp-2022-0321.PMC10211452.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quality of life in patients treated for COVID-19-associated mucormycosis at a tertiary care hospital. 在一家三甲医院接受 COVID-19 相关粘孢子虫病治疗的患者的生活质量。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-04-01 Epub Date: 2023-04-18 DOI: 10.24171/j.phrp.2022.0307
Pragya Kumar, Rajath Rao Ur, Nilanjan Roy, Deepika Agrawal, Shamshad Ahmad, Kranti Bhavana

Objectives: Coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) has emerged as a formidable infection in patients with COVID-19. The aggressive management of CAM affects quality of life (QOL); thus, this study was designed to assess the QOL in patients with CAM at a tertiary healthcare institution.

Methods: This cross-sectional study of 57 patients with CAM was conducted over 6 months using a semi-structured standard questionnaire (the abbreviated World Health Organization Quality of Life questionnaire [WHO-BREF]) and a self-rated improvement (SRI) scale ranging from 0 to 9. Cut-off values of ≤52 and <7 were considered to indicate poor QOL and poor improvement, respectively. The correlations of QOL and SRI scores were evaluated using Spearman rho values.

Results: In total, 27 patients (47.4%; 95% confidence interval [CI], 34.9%-60.1%) and 26 patients (45.6%; 95% CI, 33.4%-58.4%) had poor QOL and poor SRI scores, respectively. The overall median (interquartile range) QOL score was 52 (41-63). Headache (adjusted B, -12.3), localized facial puffiness (adjusted B , -16.4), facial discoloration (adjusted B, -23.4), loosening of teeth (adjusted B, -18.7), and facial palsy (adjusted B, -38.5) wer e significantly associated with the QOL score in patients with CAM.

Conclusion: Approximately 1 in 2 patients with CAM had poor QOL and poor improvement. Various CAM symptoms were associated with QOL in these patients. Early recognition is the key to optimal treatment, improved outcomes, and improved QOL in patients with CAM.

目的:冠状病毒病2019(COVID-19)相关粘孢子菌病(CAM)已成为COVID-19患者的一种可怕感染。对 CAM 的积极治疗会影响生活质量(QOL);因此,本研究旨在评估一家三级医疗机构中 CAM 患者的 QOL:这项横断面研究使用半结构化标准问卷(世界卫生组织生活质量问卷[WHO-BREF]缩略版)和0至9分的自评改善量表(SRI),对57名CAM患者进行了为期6个月的评估。临界值为≤52,结果为≤52:共有 27 名患者(47.4%;95% 置信区间 [CI],34.9%-60.1%)和 26 名患者(45.6%;95% 置信区间,33.4%-58.4%)的 QOL 和 SRI 评分较差。总体 QOL 评分中位数(四分位间距)为 52(41-63)分。头痛(调整后B值为-12.3)、局部面部浮肿(调整后B值为-16.4)、面部变色(调整后B值为-23.4)、牙齿松动(调整后B值为-18.7)和面部麻痹(调整后B值为-38.5)与CAM患者的QOL评分显著相关:结论:大约每 2 名 CAM 患者中就有 1 人的 QOL 较差且改善不明显。结论:大约每 2 名 CAM 患者中就有 1 人的 QOL 较差且改善不明显,各种 CAM 症状与这些患者的 QOL 相关。早期识别是对 CAM 患者进行最佳治疗、改善疗效和提高 QOL 的关键。
{"title":"Quality of life in patients treated for COVID-19-associated mucormycosis at a tertiary care hospital.","authors":"Pragya Kumar, Rajath Rao Ur, Nilanjan Roy, Deepika Agrawal, Shamshad Ahmad, Kranti Bhavana","doi":"10.24171/j.phrp.2022.0307","DOIUrl":"10.24171/j.phrp.2022.0307","url":null,"abstract":"<p><strong>Objectives: </strong>Coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) has emerged as a formidable infection in patients with COVID-19. The aggressive management of CAM affects quality of life (QOL); thus, this study was designed to assess the QOL in patients with CAM at a tertiary healthcare institution.</p><p><strong>Methods: </strong>This cross-sectional study of 57 patients with CAM was conducted over 6 months using a semi-structured standard questionnaire (the abbreviated World Health Organization Quality of Life questionnaire [WHO-BREF]) and a self-rated improvement (SRI) scale ranging from 0 to 9. Cut-off values of ≤52 and <7 were considered to indicate poor QOL and poor improvement, respectively. The correlations of QOL and SRI scores were evaluated using Spearman rho values.</p><p><strong>Results: </strong>In total, 27 patients (47.4%; 95% confidence interval [CI], 34.9%-60.1%) and 26 patients (45.6%; 95% CI, 33.4%-58.4%) had poor QOL and poor SRI scores, respectively. The overall median (interquartile range) QOL score was 52 (41-63). Headache (adjusted B, -12.3), localized facial puffiness (adjusted B , -16.4), facial discoloration (adjusted B, -23.4), loosening of teeth (adjusted B, -18.7), and facial palsy (adjusted B, -38.5) wer e significantly associated with the QOL score in patients with CAM.</p><p><strong>Conclusion: </strong>Approximately 1 in 2 patients with CAM had poor QOL and poor improvement. Various CAM symptoms were associated with QOL in these patients. Early recognition is the key to optimal treatment, improved outcomes, and improved QOL in patients with CAM.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"119-128"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a0/fe/j-phrp-2022-0307.PMC10211455.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9896804","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccine hesitancy in patients with COVID-19 who have back pain. 患有 COVID-19 并伴有背痛的患者对疫苗犹豫不决。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-04-01 Epub Date: 2023-03-24 DOI: 10.24171/j.phrp.2023.0003
Askeri Türken, Haşim Çapar

Objectives: Musculoskeletal pain is among the most common symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19), and it has placed a significant burden on health worldwide during the pandemic. This study explored vaccine hesitancy and associated factors in patients with positive COVID-19 polymerase chain reaction test results who were hospitalized and had back pain.

Methods: A cross-sectional study was conducted among 170 hospitalized COVID-19 patients over 18 years of age. Data were analyzed using descriptive statistics with IBM SPSS ver. 25.0.

Results: COVID-19 patients who were married considered COVID-19 vaccinations riskier than unmarried COVID-19 patients. Patients who had not been vaccinated expressed higher levels of distrust towards COVID-19 vaccines than patients who had been vaccinated. Participants had relatively little hesitation toward the Sinovac vaccine. High vaccine confidence was found in all participants regardless of vaccination status. Those who had not received the COVID-19 vaccine reported higher risk perceptions than those who had received at least 1 dose of any COVID-19 vaccine.

Conclusion: Measurements of the hesitancy of vaccinated and non-vaccinated patients or members of society towards vaccines can be an important parameter for health authorities to find solutions.

目的:肌肉骨骼疼痛是确诊为冠状病毒病 2019(COVID-19)患者最常见的症状之一,在大流行期间给全世界的健康造成了巨大负担。本研究探讨了COVID-19聚合酶链反应检测结果呈阳性且住院治疗并伴有背痛的患者对疫苗的犹豫态度及相关因素:方法:对 170 名 18 岁以上的 COVID-19 住院患者进行了横断面研究。使用 IBM SPSS ver.25.0 版进行描述性统计分析:已婚的 COVID-19 患者认为接种 COVID-19 疫苗的风险高于未婚的 COVID-19 患者。未接种过疫苗的患者对 COVID-19 疫苗的不信任程度高于接种过疫苗的患者。参与者对 Sinovac 疫苗的犹豫程度相对较低。无论疫苗接种情况如何,所有参与者对疫苗的信心都很高。未接种过COVID-19疫苗的人比至少接种过1剂COVID-19疫苗的人对风险的认识更高:结论:衡量已接种和未接种疫苗的患者或社会成员对疫苗的犹豫态度,可以成为卫生当局寻找解决方案的重要参数。
{"title":"Vaccine hesitancy in patients with COVID-19 who have back pain.","authors":"Askeri Türken, Haşim Çapar","doi":"10.24171/j.phrp.2023.0003","DOIUrl":"10.24171/j.phrp.2023.0003","url":null,"abstract":"<p><strong>Objectives: </strong>Musculoskeletal pain is among the most common symptoms in patients diagnosed with coronavirus disease 2019 (COVID-19), and it has placed a significant burden on health worldwide during the pandemic. This study explored vaccine hesitancy and associated factors in patients with positive COVID-19 polymerase chain reaction test results who were hospitalized and had back pain.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among 170 hospitalized COVID-19 patients over 18 years of age. Data were analyzed using descriptive statistics with IBM SPSS ver. 25.0.</p><p><strong>Results: </strong>COVID-19 patients who were married considered COVID-19 vaccinations riskier than unmarried COVID-19 patients. Patients who had not been vaccinated expressed higher levels of distrust towards COVID-19 vaccines than patients who had been vaccinated. Participants had relatively little hesitation toward the Sinovac vaccine. High vaccine confidence was found in all participants regardless of vaccination status. Those who had not received the COVID-19 vaccine reported higher risk perceptions than those who had received at least 1 dose of any COVID-19 vaccine.</p><p><strong>Conclusion: </strong>Measurements of the hesitancy of vaccinated and non-vaccinated patients or members of society towards vaccines can be an important parameter for health authorities to find solutions.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"100-109"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/85/92/j-phrp-2023-0003.PMC10211457.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526203","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the comment of Perone by the corresponding author Kim. 对通讯作者Kim对《人物》的评论的回应。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-04-01 DOI: 10.24171/j.phrp.2023.0072R
Yongmoon Kim, Bryan Inho Kim, Sangwoo Tak
{"title":"Response to the comment of Perone by the corresponding author Kim.","authors":"Yongmoon Kim,&nbsp;Bryan Inho Kim,&nbsp;Sangwoo Tak","doi":"10.24171/j.phrp.2023.0072R","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0072R","url":null,"abstract":"","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"147"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/17/27/j-phrp-2023-0072R.PMC10211451.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for deaths associated with COVID-19 according to the cause of death classification in Republic of Korea. 根据大韩民国的死因分类,与COVID-19相关的死亡风险因素。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-04-01 DOI: 10.24171/j.phrp.2022.0312
Na-Young Kim, Seong-Sun Kim, Hyun Ju Lee, Dong Hwi Kim, Boyeong Ryu, Eunjeong Shin, Donghyok Kwon

Objectives: This study aimed to classify coronavirus disease 2019 (COVID-19)-related deaths according to whether COVID-19 was listed as the cause of death, and to investigate the differences in demographic characteristics and risk factors for COVID-19 death classifications.

Methods: A total of 5,625 deaths in South Korea among patients with confirmed COVID-19 from January 20, 2020 to December 31, 2021 were selected. Excluding false reports and unnatural deaths, 5,597 deaths were analyzed. Based on death report data, deaths were classified according to whether the cause of death was listed as COVID-19 (CD) or not (NCD). The epidemiological characteristics and causes of deaths were investigated using descriptive, univariate, and multivariate statistical analyses. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to analyze the risk factors.

Results: The case fatality ratio was 0.89% and increased with age. Additionally, 96.4% of the subjects had an underlying disease, and 53.4% died in winter. The proportion of NCDs was 9.3%, of whom 19.1% died at home and 39.0% were confirmed to have COVID-19 after death. Malignant neoplasms (102/416 vs. 637/4,442; OR, 1.71; 95% CI, 1.36-2.16; p<0.001) were significantly associated with NCD.

Conclusion: This is the first study to analyze risk factors by cause of death using COVID-19 death report data in South Korea. These results are expected to be used as evidence for establishing a death monitoring system that can collect timely information in a new infectious disease pandemic.

目的:本研究旨在根据是否将COVID-19列为死亡原因对2019冠状病毒病(COVID-19)相关死亡进行分类,并探讨COVID-19死亡分类的人口学特征和危险因素的差异。方法:选取2020年1月20日至2021年12月31日在韩国确诊的COVID-19患者中死亡的5625例病例。排除虚假报告和非正常死亡,共分析了5597例死亡。根据死亡报告数据,根据死亡原因是否列为COVID-19 (CD)或非传染性疾病(NCD)对死亡进行分类。采用描述性、单变量和多变量统计分析调查流行病学特征和死亡原因。计算优势比(ORs)和95%置信区间(ci)来分析危险因素。结果:病死率为0.89%,随年龄增长呈上升趋势。此外,96.4%的受试者有基础疾病,53.4%的受试者在冬季死亡。非传染性疾病比例为9.3%,其中19.1%在家中死亡,39.0%死后确诊为COVID-19。恶性肿瘤(102/416 vs. 637/ 4442;或者,1.71;95% ci, 1.36-2.16;结论:这是第一个使用韩国COVID-19死亡报告数据按死亡原因分析危险因素的研究。这些结果有望作为建立死亡监测系统的依据,以便在新的传染病大流行中及时收集信息。
{"title":"Risk factors for deaths associated with COVID-19 according to the cause of death classification in Republic of Korea.","authors":"Na-Young Kim,&nbsp;Seong-Sun Kim,&nbsp;Hyun Ju Lee,&nbsp;Dong Hwi Kim,&nbsp;Boyeong Ryu,&nbsp;Eunjeong Shin,&nbsp;Donghyok Kwon","doi":"10.24171/j.phrp.2022.0312","DOIUrl":"https://doi.org/10.24171/j.phrp.2022.0312","url":null,"abstract":"<p><strong>Objectives: </strong>This study aimed to classify coronavirus disease 2019 (COVID-19)-related deaths according to whether COVID-19 was listed as the cause of death, and to investigate the differences in demographic characteristics and risk factors for COVID-19 death classifications.</p><p><strong>Methods: </strong>A total of 5,625 deaths in South Korea among patients with confirmed COVID-19 from January 20, 2020 to December 31, 2021 were selected. Excluding false reports and unnatural deaths, 5,597 deaths were analyzed. Based on death report data, deaths were classified according to whether the cause of death was listed as COVID-19 (CD) or not (NCD). The epidemiological characteristics and causes of deaths were investigated using descriptive, univariate, and multivariate statistical analyses. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to analyze the risk factors.</p><p><strong>Results: </strong>The case fatality ratio was 0.89% and increased with age. Additionally, 96.4% of the subjects had an underlying disease, and 53.4% died in winter. The proportion of NCDs was 9.3%, of whom 19.1% died at home and 39.0% were confirmed to have COVID-19 after death. Malignant neoplasms (102/416 vs. 637/4,442; OR, 1.71; 95% CI, 1.36-2.16; p<0.001) were significantly associated with NCD.</p><p><strong>Conclusion: </strong>This is the first study to analyze risk factors by cause of death using COVID-19 death report data in South Korea. These results are expected to be used as evidence for establishing a death monitoring system that can collect timely information in a new infectious disease pandemic.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"89-99"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/96/j-phrp-2022-0312.PMC10211456.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9577101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comments on the article "Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates". 对《21个国家COVID-19病死率的时间序列比较及多协变量调整》一文的评论。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-04-01 DOI: 10.24171/j.phrp.2023.0072L
Gaetano Perone
To the Editor: I read the recently published article by Kim et al. [1]. On page 424 [1], the authors state, referring to my paper [2], that “other research using time-series cross-sectional data appears to have underestimated the impact of autocorrelation and heteroscedasticity”. However, this statement is incorrect and unfounded for 2 reasons. First, I used cross-sectional data rather than panel data, so there was no time component. The corollary is that residuals cannot be serially correlated. It makes no sense to consider autocorrelation in this case. Second, as shown in Section 5.1 of Perone [2], I safely considered heteroscedasticity in my paper: “Furthermore, since Breusch and Pagan (1979) and Shapiro and Wilk (1965) tests allowed to accept the null hypothesis of homoscedasticity and normality of residuals, models seemed well specified. However, due to the small sample, I preferred to adopt a conservative approach, by applying the HC2 correction proposed by MacKinnon and White (1985)” [3−5]. As a result, autocorrelation and heteroscedasticity issues have no bearing on the results of my paper. Notes
{"title":"Comments on the article \"Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates\".","authors":"Gaetano Perone","doi":"10.24171/j.phrp.2023.0072L","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0072L","url":null,"abstract":"To the Editor: I read the recently published article by Kim et al. [1]. On page 424 [1], the authors state, referring to my paper [2], that “other research using time-series cross-sectional data appears to have underestimated the impact of autocorrelation and heteroscedasticity”. However, this statement is incorrect and unfounded for 2 reasons. First, I used cross-sectional data rather than panel data, so there was no time component. The corollary is that residuals cannot be serially correlated. It makes no sense to consider autocorrelation in this case. Second, as shown in Section 5.1 of Perone [2], I safely considered heteroscedasticity in my paper: “Furthermore, since Breusch and Pagan (1979) and Shapiro and Wilk (1965) tests allowed to accept the null hypothesis of homoscedasticity and normality of residuals, models seemed well specified. However, due to the small sample, I preferred to adopt a conservative approach, by applying the HC2 correction proposed by MacKinnon and White (1985)” [3−5]. As a result, autocorrelation and heteroscedasticity issues have no bearing on the results of my paper. Notes","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 2","pages":"146"},"PeriodicalIF":4.3,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/db/f9/j-phrp-2023-0072L.PMC10211453.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9526206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early countermeasures to COVID-19 at long-term care facilities in Gwangju Metropolitan City, Republic of Korea. 韩国光州长期护理机构的COVID-19早期对策
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-02-01 DOI: 10.24171/j.phrp.2022.0293
Hye-Jin Kim, Jieun Kim, Yoon Suk Jang, Hanul Park, Jong Mu Kim, Young Joon Park, So-Yeon Ryu, Jun Hwi Cho, So Yeong Park, Sang-Eun Lee

Objectives: The coronavirus disease 2019 (COVID-19) pandemic has continued since its first detection in the Republic of Korea on January 20, 2020. This study describes the early countermeasures used to minimize the risk of COVID-19 outbreaks during cohort quarantine and compares the epidemiological characteristics of 2 outbreaks in long-term care facilities (LTCFs) in Gwangju Metropolitan City in summer 2020.

Methods: An epidemiological investigation was conducted via direct visits. We investigated epidemiological characteristics, including incidence, morbidity, and mortality rates, for all residents and staff members. Demographic characteristics were analyzed using a statistical program. Additionally, the method of managing infection in LTCFs is described.

Results: Residents and caregivers had high incidence rates in LTCF-A and LTCF-B, respectively. LTCF-B had a longer quarantine period than LTCF-A. The attack rate was 20.02% in LTCF-A and 27.9% in LTCF-B. The mortality rate was 2.3% (1/43) in LTCF-B, the only facility in which a COVID-19 death occurred.

Conclusions: Extensive management requires contact minimization, which involves testing all contacts to mitigate further transmission in the early stages of LTCF outbreaks. The findings of this study can help inform and prepare public health authorities for COVID-19 outbreaks, particularly for early control in vulnerable facilities.

2019冠状病毒病(COVID-19)自2020年1月20日在韩国首次发现以来,大流行仍在继续。本研究描述了在队列隔离期间为尽量减少COVID-19爆发风险而采取的早期对策,并比较了2020年夏季在光州长期护理机构(ltcf)发生的两起疫情的流行病学特征。方法:采用直接访视的方法进行流行病学调查。我们调查了所有居民和工作人员的流行病学特征,包括发病率、发病率和死亡率。使用统计程序分析人口统计学特征。此外,还描述了ltcf中管理感染的方法。结果:居民和护理人员LTCF-A和LTCF-B的发病率分别较高。LTCF-B的隔离期比LTCF-A长。LTCF-A和LTCF-B的发病率分别为20.02%和27.9%。LTCF-B的死亡率为2.3%(1/43),这是唯一发生COVID-19死亡的设施。结论:广泛管理需要最大限度地减少接触,这包括对所有接触者进行检测,以在LTCF暴发的早期阶段减轻进一步传播。这项研究的结果可以帮助公共卫生当局为COVID-19疫情提供信息并做好准备,特别是在脆弱设施中进行早期控制。
{"title":"Early countermeasures to COVID-19 at long-term care facilities in Gwangju Metropolitan City, Republic of Korea.","authors":"Hye-Jin Kim,&nbsp;Jieun Kim,&nbsp;Yoon Suk Jang,&nbsp;Hanul Park,&nbsp;Jong Mu Kim,&nbsp;Young Joon Park,&nbsp;So-Yeon Ryu,&nbsp;Jun Hwi Cho,&nbsp;So Yeong Park,&nbsp;Sang-Eun Lee","doi":"10.24171/j.phrp.2022.0293","DOIUrl":"https://doi.org/10.24171/j.phrp.2022.0293","url":null,"abstract":"<p><strong>Objectives: </strong>The coronavirus disease 2019 (COVID-19) pandemic has continued since its first detection in the Republic of Korea on January 20, 2020. This study describes the early countermeasures used to minimize the risk of COVID-19 outbreaks during cohort quarantine and compares the epidemiological characteristics of 2 outbreaks in long-term care facilities (LTCFs) in Gwangju Metropolitan City in summer 2020.</p><p><strong>Methods: </strong>An epidemiological investigation was conducted via direct visits. We investigated epidemiological characteristics, including incidence, morbidity, and mortality rates, for all residents and staff members. Demographic characteristics were analyzed using a statistical program. Additionally, the method of managing infection in LTCFs is described.</p><p><strong>Results: </strong>Residents and caregivers had high incidence rates in LTCF-A and LTCF-B, respectively. LTCF-B had a longer quarantine period than LTCF-A. The attack rate was 20.02% in LTCF-A and 27.9% in LTCF-B. The mortality rate was 2.3% (1/43) in LTCF-B, the only facility in which a COVID-19 death occurred.</p><p><strong>Conclusions: </strong>Extensive management requires contact minimization, which involves testing all contacts to mitigate further transmission in the early stages of LTCF outbreaks. The findings of this study can help inform and prepare public health authorities for COVID-19 outbreaks, particularly for early control in vulnerable facilities.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 1","pages":"59-65"},"PeriodicalIF":4.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/32/f7/j-phrp-2022-0293.PMC10211439.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How we will reach a safer community. 我们将如何建立一个更安全的社区。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-02-01 DOI: 10.24171/j.phrp.2023.0057
Jong-Koo Lee
At the end of last year, the Republic of Korea, China, and Japan responded to concerns about the increase in new coronavirus disease 2019 (COVID-19) patients and the emergence of new variants by strengthening their surveillance and quarantine measures. However, contrary to these concerns, the number of new cases and deaths decreased globally, and some have expressed the opinion that the World Health Organization (WHO) should reevaluate the declaration of a global public health crisis. However, the decision has been made to maintain the crisis status for the time being [1]. Nevertheless, in the first week of January, when the Rt value dropped below 1, the Republic of Korea implemented an exit strategy and has enforced it since January 30 [2]. The use of masks in public health facilities where a large number of people gather is now at individuals’ discretion, while their use is mandatory in public transportation. And, it is necessary to transition to a long-term strategy based on the endemicity of COVID-19. In the United States, the BXX. 1.5 variant has become predominant, but it is expected to be resolved by May 11th [3]. Therefore, the search for an exit strategy should consider which measures should be prioritized to prepare for the next pandemic. Building public trust in the safety and efficacy of currently available COVID-19 vaccines is of the utmost importance. Nationwide vaccination and booster programs have been initiated to curb the ongoing pandemic. During the vaccination campaign over the past 3 years, reports of vaccine adverse events have led to the need for research on the epidemiological relationship between vaccination and serious illnesses. To ensure scientific and objective judgments regarding this issue, the government has entrusted research on the adverse effects of COVID-19 vaccinations to the National Academy of Medicine of Korea. The study by Jeong et al. [4] published in this issue summarizes the methods used to research important adverse events following immunization; the ultimate goal of this research program is to increase the reliability of vaccines and combat vaccine hesitancy among medical professionals and the public. The second measure that must be prioritized is the improvement of governance by amending laws and regulations related to infectious diseases. After the Middle East respiratory syndrome outbreak in 2015, the government introduced a legal system that classifies reporting and quarantine methods for disease management based on the severity of each disease group. However, the severity of COVID-19 can change depending on vaccination or mutations in the virus. Thus, the government has changed the classification of COVID-19 from a level 1 disease, which requires immediate reporting, isolation, and treatment cost support, to a level 4 disease, which requires self-payment of treatment and surveillance. This adjustment of the severity level has created confusion in its management and procedural problems related to
{"title":"How we will reach a safer community.","authors":"Jong-Koo Lee","doi":"10.24171/j.phrp.2023.0057","DOIUrl":"https://doi.org/10.24171/j.phrp.2023.0057","url":null,"abstract":"At the end of last year, the Republic of Korea, China, and Japan responded to concerns about the increase in new coronavirus disease 2019 (COVID-19) patients and the emergence of new variants by strengthening their surveillance and quarantine measures. However, contrary to these concerns, the number of new cases and deaths decreased globally, and some have expressed the opinion that the World Health Organization (WHO) should reevaluate the declaration of a global public health crisis. However, the decision has been made to maintain the crisis status for the time being [1]. Nevertheless, in the first week of January, when the Rt value dropped below 1, the Republic of Korea implemented an exit strategy and has enforced it since January 30 [2]. The use of masks in public health facilities where a large number of people gather is now at individuals’ discretion, while their use is mandatory in public transportation. And, it is necessary to transition to a long-term strategy based on the endemicity of COVID-19. In the United States, the BXX. 1.5 variant has become predominant, but it is expected to be resolved by May 11th [3]. Therefore, the search for an exit strategy should consider which measures should be prioritized to prepare for the next pandemic. Building public trust in the safety and efficacy of currently available COVID-19 vaccines is of the utmost importance. Nationwide vaccination and booster programs have been initiated to curb the ongoing pandemic. During the vaccination campaign over the past 3 years, reports of vaccine adverse events have led to the need for research on the epidemiological relationship between vaccination and serious illnesses. To ensure scientific and objective judgments regarding this issue, the government has entrusted research on the adverse effects of COVID-19 vaccinations to the National Academy of Medicine of Korea. The study by Jeong et al. [4] published in this issue summarizes the methods used to research important adverse events following immunization; the ultimate goal of this research program is to increase the reliability of vaccines and combat vaccine hesitancy among medical professionals and the public. The second measure that must be prioritized is the improvement of governance by amending laws and regulations related to infectious diseases. After the Middle East respiratory syndrome outbreak in 2015, the government introduced a legal system that classifies reporting and quarantine methods for disease management based on the severity of each disease group. However, the severity of COVID-19 can change depending on vaccination or mutations in the virus. Thus, the government has changed the classification of COVID-19 from a level 1 disease, which requires immediate reporting, isolation, and treatment cost support, to a level 4 disease, which requires self-payment of treatment and surveillance. This adjustment of the severity level has created confusion in its management and procedural problems related to ","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 1","pages":"1-4"},"PeriodicalIF":4.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f4/fa/j-phrp-2023-0057.PMC10211445.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The first reported hepatitis E outbreak in a food manufacturing factory: Korea, 2022. 首次报告的戊型肝炎疫情发生在食品制造厂:韩国,2022年。
IF 4.3 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Pub Date : 2023-02-01 DOI: 10.24171/j.phrp.2022.0305
Hansol Yeom, Soonryu Seo, Youngsil Yoon, Jaeeun Lee, Myung-Guk Han, Deog-Yong Lee, Sun-Whan Park, Song A Park, Sook-Hyang Jeong, Jin Gwack

Objectives: On February 16, 2022, 12 cases of hepatitis E virus (HEV) infection were reported in a food manufacturing factory in Korea. The aim of this study was to identify additional cases and to determine the source of this HEV outbreak.

Methods: This study was an in-depth investigation of 12 HEV immunoglobulin M (IgM)-positive cases and their demographic, clinical, and epidemiological characteristics. On-site specimens were collected from the environment and from humans, and a follow-up investigation was conducted 2 to 3 months after the outbreak.

Results: Among 80 production workers in the factory, 12 (15.0%) had acute HEV infection, all of whom were asymptomatic. The follow-up investigation showed that 3 cases were HEV IgMpositive, while 6 were HEV IgG-positive. HEV genes were not detected in the HEV IgM-positive specimens. HEV genes were not detected in the food products or environmental specimens collected on-site. HEV was presumed to be the causative pathogen. However, it could not be confirmed that the source of infection was common consumption inside the factory.

Conclusions: This was the first domestic case of an HEV infection outbreak in a food manufacturing factory in Korea. Our results provide information for the future control of outbreaks and for the preparation of measures to prevent domestic outbreaks of HEV infection.

目的:2022年2月16日,韩国一家食品制造厂报告了12例戊型肝炎病毒(HEV)感染。这项研究的目的是确定其他病例并确定HEV暴发的来源。方法:本研究对12例HEV免疫球蛋白M (IgM)阳性病例及其人口学、临床和流行病学特征进行了深入调查。从环境和人类中收集了现场标本,并在疫情发生2至3个月后进行了后续调查。结果:该厂80名生产工人中有12人(15.0%)急性HEV感染,均无症状。随访结果:3例HEV igg阳性,6例HEV igg阳性。HEV igm阳性标本中未检出HEV基因。在现场采集的食品或环境标本中未检出HEV基因。推测HEV为致病病原体。但是,目前还不能确定传染源是工厂内的普通消费。结论:这是韩国国内食品制造厂暴发的首例戊肝病毒感染病例。本研究结果为今后控制暴发和制定预防国内HEV感染暴发的措施提供了信息。
{"title":"The first reported hepatitis E outbreak in a food manufacturing factory: Korea, 2022.","authors":"Hansol Yeom,&nbsp;Soonryu Seo,&nbsp;Youngsil Yoon,&nbsp;Jaeeun Lee,&nbsp;Myung-Guk Han,&nbsp;Deog-Yong Lee,&nbsp;Sun-Whan Park,&nbsp;Song A Park,&nbsp;Sook-Hyang Jeong,&nbsp;Jin Gwack","doi":"10.24171/j.phrp.2022.0305","DOIUrl":"https://doi.org/10.24171/j.phrp.2022.0305","url":null,"abstract":"<p><strong>Objectives: </strong>On February 16, 2022, 12 cases of hepatitis E virus (HEV) infection were reported in a food manufacturing factory in Korea. The aim of this study was to identify additional cases and to determine the source of this HEV outbreak.</p><p><strong>Methods: </strong>This study was an in-depth investigation of 12 HEV immunoglobulin M (IgM)-positive cases and their demographic, clinical, and epidemiological characteristics. On-site specimens were collected from the environment and from humans, and a follow-up investigation was conducted 2 to 3 months after the outbreak.</p><p><strong>Results: </strong>Among 80 production workers in the factory, 12 (15.0%) had acute HEV infection, all of whom were asymptomatic. The follow-up investigation showed that 3 cases were HEV IgMpositive, while 6 were HEV IgG-positive. HEV genes were not detected in the HEV IgM-positive specimens. HEV genes were not detected in the food products or environmental specimens collected on-site. HEV was presumed to be the causative pathogen. However, it could not be confirmed that the source of infection was common consumption inside the factory.</p><p><strong>Conclusions: </strong>This was the first domestic case of an HEV infection outbreak in a food manufacturing factory in Korea. Our results provide information for the future control of outbreaks and for the preparation of measures to prevent domestic outbreaks of HEV infection.</p>","PeriodicalId":38949,"journal":{"name":"Osong Public Health and Research Perspectives","volume":"14 1","pages":"15-22"},"PeriodicalIF":4.3,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/72/j-phrp-2022-0305.PMC10211441.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9525701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Osong Public Health and Research Perspectives
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1